Assessing long-run economic benefits attributed to an IVF-conceived singleton based on projected lifetime net tax contributions in the UK
The DOI matches its Crossref record; 23 of the 24 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Over the past decade, demand for fertility treatments has increased as a result of delaying time to first pregnancy and growing awareness and acceptance of available treatment options. Despite increasing demand, health authorities often view infertility as a low health priority and consequently limit access to treatments by rationing and limiting funds. METHODS: To assess the long-term economic benefits attributed to in vitro fertilization (IVF)-conceived children, we developed a health investment model to evaluate whether state-funded IVF programmes in the UK represent sound fiscal policies. Based on the average investment cost to conceive an IVF singleton, we describe the present value of net taxes derived from gross taxes paid minus direct government transfers received (e.g. education, health, pension) over the lifetime of the child. To establish the present value of investing in IVF, we have discounted all costs from benefits (i.e. lifetime taxes paid) using UK Treasury department rates based on a singleton delivery with similar characteristics for education, earnings, health and life expectancy to a naturally conceived child. RESULTS: The lifetime discounted value of net taxes from an IVF-conceived child with mother aged 35 is pound 109,939 compared with pound 122,127 for a naturally conceived child. The lifetime undiscounted net tax contribution for the IVF-conceived child and naturally conceived child are pound 603,000 and pound 616,000, respectively. CONCLUSIONS: An investment of pound 12,931 to achieve an IVF singleton is actually worth 8.5-times this amount to the UK Treasury in discounted future tax revenue. The analysis underscores that costs to the health sector are actually investments when a broader government perspective is considered over a longer period of time.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For instance, lifetime revenue from tax-paying citizens, calculated in the UK, was eight times the return on investment from the total cost of fertility care (Connolly et al., 2009).”
From Declining global fertility rates and the implications for family planning and family building: an IFFS consensus document based on a narrative review of the literature (2024) · cites this paper as Connolly et al., 2009
Citations
Cites
On the Concept of Health Capital and the Demand for Health
Grossman, M. (1972) · Journal of Political Economy · doi:10.1086/259880 · Cited by 5,951
1. On the Concept of Health Capital and the Demand for Health
Grossman, M. (2017) · Determinants of Health · doi:10.7312/gros17812-004 · Cited by 3,991
The American Journal of Managed Care
(2020) · The American Journal of Managed Care · doi:10.37765/ajmc · Cited by 3,237
Is Technological Change In Medicine Worth It?
Cutler, D. M., & McClellan, M. (2001) · Health Affairs · doi:10.1377/hlthaff.20.5.11 · Cited by 377
Generational Accounting around the World
Auerbach, A. J., Kotlikoff, L. J., & Leibfritz, W. (1999) · University of Chicago Press eBooks · doi:10.7208/chicago/9780226032184.001.0001 · Cited by 341
Does The Aging Of The Population Really Drive The Demand For Health Care?
Reinhardt, U. E. (2003) · Health Affairs · doi:10.1377/hlthaff.22.6.27 · Cited by 267
Generational Accounting: Knowing Who Pays, and When, for What We Spend
Kotlikoff, L. J. (1992) · Medical Entomology and Zoology · Cited by 219
Generational Accounting in the UK
Cardarelli, R., Sefton, J., & Kotlikoff, L. J. (2000) · The Economic Journal · doi:10.1111/1468-0297.00573 · Cited by 144
NYBOE ANDERSEN, A., & ERB, K. (2006) · International Journal of Andrology · doi:10.1111/j.1365-2605.2005.00577.x · Cited by 131
Our Future Health Secured?: A Review of NHS Funding and Performance
Wanless, D., Appleby, J., Harrison, A., & Patel, D. P. (2007) · Cited by 130
Research works printed but not linked: 2
- 2005, AGEING HORIZONS, 2, 15
- 2007, PHARM POLICY LAW, 9, 221
Cited by
Fauser, B. C. J. M., Adamson, G. D., Boivin, J., Chambers, G. M., de Geyter, C., Dyer, S., Inhorn, M. C., Schmidt, L., Serour, G. I., Tarlatzis, B., et al. (2024) · Human Reproduction Update · doi:10.1093/humupd/dmad028 · Cited by 224
“For instance, lifetime revenue from tax-paying citizens, calculated in the UK, was eight times the return on investment from the total cost of fertility care (Connolly et al. , 2009).”
BackgroundThe costs and consequences of assisted reproductive technology: an economic perspective
Connolly, M. P., Hoorens, S., Chambers, G. M., & on behalf of the ESHRE Reproduction and Society Task Force (2010) · Human Reproduction Update · doi:10.1093/humupd/dmq013 · Cited by 197
“…by guest on 29 July 2018 from a government perspective in Sweden (Svensson et al., 2008), the USA (Connolly et al., 2008) and the UK (Connolly et al., 2009b) by applying a generational accounting framework to evaluate ART funding policies…”
BackgroundSelf-citationSiristatidis, C., Sergentanis, T. N., Kanavidis, P., Trivella, M., Sotiraki, M., Mavromatis, I., Psaltopoulou, T., Skalkidou, A., & Petridou, E. T. (2013) · Human Reproduction Update · doi:10.1093/humupd/dms051 · Cited by 174
“…need to pursue career opportunities, along with the growing awareness of treatment options, are linked with advanced maternal age, whereas ovarian ageing and infertility seem counterbalanced by the success of assisted reproduction technologies (ARTs) (Connolly et al., 2009; Kimberly et al., 2012).”
BackgroundAcceptable cost for the patient and society
Chambers, G. M., Adamson, G. D., & Eijkemans, M. J. C. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.06.017 · Cited by 116
Busnelli, A., Papaleo, E., Prato, D. D., Vecchia, I. L., Iachini, E., Paffoni, A., Candiani, M., & Somigliana, E. (2014) · Human Reproduction · doi:10.1093/humrep/deu319 · Cited by 119
“However, the complete exclusion of this potential stakeholder is arguable (Connolly et al., 2009; Chambers et al., 2013).”
BackgroundIVF and breast cancer: a systematic review and meta-analysis
Sergentanis, T. Ν., Diamantaras, A.-A., Perlepe, C., Kanavidis, P., Skalkidou, A., & Petridou, E. T. (2013) · Human Reproduction Update · doi:10.1093/humupd/dmt034 · Cited by 125
Economic aspects of infertility care: a challenge for researchers and clinicians: Figure 1
(2015) · Human Reproduction · doi:10.1093/humrep/dev163 · Cited by 89
“estimated that the discounted net tax of an ART singleton child born in 2005 in the UK was 208 400 USD, corresponding to an 8-fold return on investment for the government (Connolly et al., 2009).”
Connolly, M. P., Kotsopoulos, N., Postma, M. J., & Bhatt, A. (2017) · Value in Health · doi:10.1016/j.jval.2016.11.018 · Cited by 61
Self-citationChambers, G. M., Hoang, V. P., Zhu, R., & Illingworth, P. J. (2012) · BMC Health Services Research · doi:10.1186/1472-6963-12-142 · Cited by 53
COPD in the Working Age Population: The Economic Impact on Both Patients and Government
van Boven, J. F. M., Vegter, S., van der Molen, T., & Postma, M. J. (2013) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2013.813446 · Cited by 47
Cost-effectiveness of ‘immediate IVF’ versus ‘delayed IVF’: a prospective study
Eijkemans, M. J. C., Kersten, F. A. M., Lintsen, A. M. E., Hunault, C. C., Bouwmans, C. A. M., Roijen, L. H., Habbema, J. D. F., & Braat, D. D. M. (2017) · Human Reproduction · doi:10.1093/humrep/dex018 · Cited by 40
Connolly, M. P., Ledger, W. J., & Postma, M. J. (2009) · Human Fertility · doi:10.3109/14647270903401747 · Cited by 27
Self-citationAchieving more equitable access to assisted reproduction
Dyer, S., Adamson, G. D., Inhorn, M. C., & Zegers-Hochschild, F. (2024) · BMJ · doi:10.1136/bmj-2023-077111 · Cited by 19
“41 42 Furthermore, although treatment is costly to individuals, it has beendeemedaffordableformanysocieties.”
Backgroundvan Heesch, M. M. J., van Asselt, A. D. I., Evers, J. L. H., van der Hoeven, M. A. H. B. M., Dumoulin, J. C. M., van Beijsterveldt, C. E. M., Bonsel, G. J., Dykgraaf, R., van Goudoever, J. B., Koopman-Esseboom, C., et al. (2016) · Human Reproduction · doi:10.1093/humrep/dew229 · Cited by 20
Economic value of in vitro fertilization in Ukraine, Belarus, and Kazakhstan
Mandrik, O., Knies, S., & Severens, J. L. (2015) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s79513 · Cited by 15
Connolly, M. P., Panda, S., Mburu, G., Matsaseng, T., & Kiarie, J. (2021) · Reproductive Biomedicine & Society Online · doi:10.1016/j.rbms.2020.08.001 · Cited by 14
“In contrast, the field of public economics regularly applies frameworks by which the child can be valued as a future member of society (Connolly et al., 2008; Wolf et al., 2011).”
BackgroundSelf-citationZhao, J., Li, Y., Zhang, Q., & Wang, Y. (2015) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2015.03.008 · Cited by 14
RetractedReproductive ageing and fertility in an ageing population
Cooke, L., & Nelson, S. M. (2011) · The Obstetrician & Gynaecologist · doi:10.1576/toag.13.3.161.27668 · Cited by 15
Peeraer, K., D’Hooghe, T. M., Vandoren, C., Trybou, J., Spiessens, C., Debrock, S., & Neubourg, D. D. (2017) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2017.05.015 · Cited by 13
Carpinello, O. J., Casson, P. R., Kuo, C., Raj, R. S., Sills, E. S., & Jones, C. A. (2016) · Applied Health Economics and Health Policy · doi:10.1007/s40258-016-0237-2 · Cited by 13
The long-term fiscal impact of funding cuts to Danish public fertility clinics
Connolly, M. P., Postma, M. J., Crespi, S., Andersen, A. N., & Ziebe, S. (2011) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2011.09.011 · Cited by 18
“In contrast with previous studies employing this methodological framework that considered an IVF singleton (Connolly et al., 2009a), the current study directly assesses a policy change introduced 1n January 2011 and applies the method to the annual birth cohort of assisted-conception children in…”
BackgroundMethodInfluentialSelf-citationMatorras, R., Chaudhari, V., Roeder, C., Schwarze, J.-E., Bühler, K. F., Hwang, K. J., Chang-Woo, C., Iniesta, S., D’Hooghe, T., & Mathur, R. (2023) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2023.102349 · Cited by 15
Chen, M., Kotsopoulos, N., Yen, A. M., Lin, K., & Connolly, M. P. (2024) · Human Reproduction · doi:10.1093/humrep/deae271 · Cited by 11
“In the context of assisted reproduction, it is a useful tool to evaluate lifetime transactions that children born from reproductive technologies are likely to have with their government in relation to future taxes and public benefits received (Connolly et al. , 2009).”
Self-citationLuyten, J., Connolly, M. P., Verbeke, E., Bühler, K. F., Scotland, G., Lispi, M., Revelli, A., Borget, I., Cédrin‐Durnerin, I., & D’Hooghe, T. (2022) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2022.01.008 · Cited by 17
“The government perspective cost-bene fi t framework has been applied in several previous studies, to inform allocative ef fi ciency by capturing the lifetime net tax contributions attributed to MAR-conceived children [25,26].”
Self-citationGhinea, N., Wiersma, M., Newson, A. J., Walby, C., Norman, R. J., & Lipworth, W. L. (2022) · Human Reproduction Open · doi:10.1093/hropen/hoac052 · Cited by 17
“In the UK and the USA, economic modelling has shown that an IVF-conceived child will generate up to 8.5 times the procedure’s cost in tax revenue (Connolly et al., 2008, 2009), while a Swedish study also demonstrated that IVFconceived children provide positive net returns to their nations (Svensson…”
InfluentialFragoulakis, V., & Maniadakis, N. (2013) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s44784 · Cited by 14
“For instance, in the case of the UK, a 1.9% productivity growth estimate was determined for a similar model by Connolly et al. 16 Nonetheless, it must be highlighted that labor productivity is calculated by dividing the real output of the economy by the total working hours of employment.”
InfluentialAppiah, D., & Ganle, J. K. (2024) · BMC Medical Ethics · doi:10.1186/s12910-024-01113-0 · Cited by 10
The fiscal outcome of artificial conception in Brazil--creating citizens in developing countries
Kröger, G. B., & Ejzenberg, D. (2011) · Human Reproduction · doi:10.1093/humrep/der370 · Cited by 9
“5% (Connolly et al., 2009).”
Double trouble: Should double embryo transfer be banned?
Wilkinson, D. J. C., Schaefer, G. O., Tremellen, K. P., & Savulescu, J. (2015) · Metamedicine · doi:10.1007/s11017-015-9324-x · Cited by 10
“Such modelling suggests that there is a net economic benefit of £110,000, or US$155,000, for each child conceived by IVF [59, 60].”
BackgroundCosts and benefits of individuals conceived after IVF: a net tax evaluation in The Netherlands
Moolenaar, L. M., Connolly, M., Huisman, B., Postma, M. J., Hompes, P. G. A., van der Veen, F., & Mol, B. W. J. (2014) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2013.10.002 · Cited by 8
“Calculation in the UK showed a positive return of 850% of the initial investment to the government (Connolly et al., 2009).”
BackgroundSelf-citationValuing live births from assisted reproduction: a health economics viewpoint
Martins, R., & Connolly, M. P. (2022) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2022.10.003 · Cited by 8
Self-citationKeane, M. G., Long, J., O’Nolan, G., & Farragher, L. (2017) · Lenus, The Irish Health Repository (Dr Steevens Hospital Library) · doi:10.13140/rg.2.2.35876.58248 · Cited by 14
Feasibility analysis of China's medical insurance coverage of assisted reproductive technology
Huang, R., Yu, J.-Y., He, W., & Liu, R.-H. (2024) · Scientific Reports · doi:10.1038/s41598-024-58640-4 · Cited by 10
Economic evaluation of anti-epileptic drug therapies with specific focus on teratogenic outcomes
Jentink, J., Boersma, C., den Berg, L. T. W. D. J., & Postma, M. J. (2012) · Journal of Medical Economics · doi:10.3111/13696998.2012.684366 · Cited by 10
Matorras, R., Villoro, R., Domínguez, A. G., Pérez-Camarero, S., Hidalgo‐Vega, Á., & Polanco, C. (2015) · Reproductive Biomedicine & Society Online · doi:10.1016/j.rbms.2016.04.001 · Cited by 9
Federalism and Responsibility for Health Care
MacKay, D., & Danis, M. (2016) · Cited by 7
Health care as an investment: Implications for an era of ageing populations
Connolly, M. P., & Postma, M. J. (2009) · Journal of Medical Marketing Device Diagnostic and Pharmaceutical Marketing · doi:10.1057/jmm.2009.43 · Cited by 6
Self-citationHua, X., Rivero‐Arias, O., QUIGLEY, M. A., Kurinczuk, J. J., & Carson, C. (2023) · Human Reproduction · doi:10.1093/humrep/dead198 · Cited by 6
“…the long-term broader economic consequences of children born following ART from the perspective of the government and found that an investment of £12 931 to achieve an IVF singleton was worth 8.5 times this amount to the UK Treasury in discounted future tax revenue (Connolly et al. , 2009).”
InfluentialIs mandating elective single embryo transfer ethically justifiable in young women?
Tremellen, K. P., Wilkinson, D. J. C., & Savulescu, J. (2015) · Reproductive Biomedicine & Society Online · doi:10.1016/j.rbms.2016.02.001 · Cited by 4
Ronan, L., McDermott, O., Butler, M., & Trubetskaya, A. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19159534 · Cited by 3
Rerception of assisted reproductive technologies by Russian student youth
Isupova, O., & Евгеньевна, Р. Н. (2021) · Народонаселение · doi:10.19181/population.2021.24.4.3 · Cited by 3
Cost implications to society of delaying childbearing
Hirshfeld‐Cytron, J. (2012) · Expert Review of Obstetrics & Gynecology · doi:10.1586/eog.12.68 · Cited by 3
Marcellusi, A., Scortichini, M., Guarnotta, G., Connolly, M. P., & Busnelli, A. (2025) · Health Economics Review · doi:10.1186/s13561-025-00672-1 · Cited by 2
“Several studies estimated the lifetime net fiscal benefit of an individual born from ART across different countries, with values ranging from 61,428 United States Dol-lars (USD) in Brazil to € 154,100 in Denmark [15, 16, 29, 30].”
Self-citationConnolly, M. P., Kotsopoulos, N., Li, J., & Chambers, G. M. (2025) · Journal of health economics and outcomes research · doi:10.36469/001c.133796 · Cited by 4
Self-citationCooke, I. D. (2016) · Springer eBooks · doi:10.1007/978-3-319-29373-8_16 · Cited by 5
The Economics of IVF: Evaluating the Necessity and Value of Public Funding
Verbeke, E., Luyten, J., & D’Hooghe, T. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108859486.010 · Cited by 2
Die Reproduktionsmedizin heute und Chancen für die Zukunft
Geyter, C. D., & Geyter, M. D. (2009) · Therapeutische Umschau · doi:10.1024/0040-5930.66.12.797 · Cited by 1
“Infrastruktur und die teure Hormonpräparaten sehr kostenintensiv sind, haben mehrere Kosten-Nutzen-Analysen ergeben, dass diese Therapieform volkswirtschaftlich eine eindeutige positive Bilanz aufweist [10,11].”
BackgroundJwa, S. C., Goto, R., Maeda, E., Kajihara, T., & Ishihara, O. (2023) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.15676 · Cited by 2
“evaluated lifetime net taxes for children born from ART and reported that the lifetime discounted and undiscounted value of net taxes paid by a child born as the result of IVF from a mother aged 35 years was 109 939 GBP and 603 000 GBP, respectively, whereas the net tax from naturally conceived children was 122 127 GB…”
BackgroundAssistert befruktning – hva skal staten betale?
Romundstad, L. B., & Sunde, A. (2012) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.12.0394 · Cited by 1
Avaliação histomorfométrica do endométrio na fase lútea de mulheres férteis e inférteis
Ejzenberg, D. (2012) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2012.tde-27112012-101043
Elective Single-Embryo Transfer Should Not Be the Standard of Care For All Patients
Adamson, G. D. (2015) · Springer eBooks · doi:10.1007/978-3-319-17849-3_13
Ethics on procreation: Does everyone have the right to found a family?
Panagiotopoulou, N. (2013) · Clinical Ethics · doi:10.1177/1477750913486243
“Last but not least, limited access to assisted reproduction hampers economic growth and development by reducing the economic base to support an ageing population.(7) We have seen that the right to found a family and the right to assisted reproductive techniques should be accorded to all.”
BackgroundJacobsen, G., & Brean, A. (2012) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.12.0732
31 The intersection between economic and ethical aspects of ART
Chambers, G. M. (2011) · De Gruyter eBooks · doi:10.1515/9783110240214.371 · Cited by 1
Jentink, J., Boersma, C., & Postma, M. J. (2012)
(2010) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0b013e32833ae363
(2017) · Advances in hospitality, tourism and the services industry (AHTSI) book series · doi:10.4018/978-1-5225-2694-0.ch002
Current options to lower the cost of in vitro fertilization: a comprehensive review
Gardner, A. B., Smith, K. L., Huuki, E., Luizzi, J. M., Gunn, D. D., Campbell, S. B., & Pier, B. D. (2022) · F&S Reviews · doi:10.1016/j.xfnr.2022.10.001
Connolly, M. P., Kotsopoulos, N., Li, J., & Chambers, G. M. (2025) · Journal of health economics and outcomes research · doi:10.36469/jheor.2025.133796 · Cited by 1
Self-citationLifetime fiscal impact of IVF-born singletons in Turkey: a female-age-stratified analysis
Lazoğlu, Ç., Kemahli, M. N. C., Ozbek, I. Y., Yıldırak, K., Mümüşoğlu, S., & Yaralí, H. (2025) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2025.105167
Recent changes in public funding of in vitro fertilization in Poland and their expected implications
Kurzawa, R., & Stabrawa, L. (2025) · Global Reproductive Health · doi:10.1097/grh.0000000000000116
Hamamah, S., Carette, J., Leleu, H., & Markert, M. (2026) · PharmacoEconomics - Open · doi:10.1007/s41669-026-00641-2
“A study of the long-term economic value of IVF-conceived singleton babies in the UK estimated the lifetime discounted net tax contributions to be approximately £110,000 (2005 values) for a baby born [34].”
Khakian, M., Souresrafil, A., Farzaneh, F., & Rezapour, A. (2026) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2026.2694563
“There have been a number of long-term financial models that show positive net tax returns (e.g. [ 26; 27]: SEK 140,000–260,000 per IVF child [9]: EUR 17,015 per live birth with an 182% return on investment).”
Metadata
- Authors
- Connolly, M., Gallo, F., Hoorens, S., & Ledger, W.
- Affiliations
- RAND Europe (GB)
- University of Sheffield (GB)
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-12-04
- Volume
- 24
- Issue
- 3
- Pages
- 626-632
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W2097778288
- Cited by
- 63
- References
- 24
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 4 · 2023: 4 · 2022: 5 · 2021: 1 · 2020: 2 · 2017: 5 · 2016: 4 · 2015: 7 · 2014: 1 · 2013: 6 · 2012: 8
- FWCI
- 3.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Reproduction (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Health and Technologies
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Assisted Reproductive Technology and Twin Pregnancy
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Keywords
- in vitro fertilization, fiscal policy, natural conception comparison, transfer payments
- MeSH terms
- Accounting, Female, Fertilization in Vitro, Financing, Government, Forecasting, United Kingdom, Health Policy, Humans, Infertility, Pensions, Pregnancy, Taxes, Health Care Costs, Models, Economic, Federal Government
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.